BridgeMD
New treatment option for Cancer Diagnosis
Official title Digital Solutions for bEtter cAre
ClinicalTrials.gov ID: NCT07416513
What this study is testing
- What it's testing
- The target population includes cancer patients, caregivers, family members, healthcare providers and mental health specialists, who will be the primary end-users of the Althea platform. For patients, survivors, caregivers, and family members, the sample variables include age, gender, type and stage of disease, and time since the first diagnosis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 and older. Healthy volunteers may be eligible.
You may be able to join if
- HEALTHCARE PROFESSIONALS:
- Healthcare professionals actually working in oncology and/or psychooncology;
- Teachers of paediatric cancer patients. ADULT POPULATION:
- Patients with a current or previous cancer diagnosis
- Adequate language proficiency,
You likely can't join if
- Healthcare professionals with limited oncology patient contact;
- Insufficient knowledge of the local language;
- Severe cognitive impairment, and/or mental disorders that prohibited their participation in the study or inadequate verbal skills that may render...
- Inability to understand the study materials (as evaluated by the clinician);
- Physical or psychological impairment that prohibits their participation in focus groups (as evaluated by the clinician).
See the full eligibility criteria
- HEALTHCARE PROFESSIONALS:
- Healthcare professionals actually working in oncology and/or psychooncology;
- Teachers of paediatric cancer patients. ADULT POPULATION:
- Patients with a current or previous cancer diagnosis
- Adequate language proficiency,
- Able to provide informed consent; PAEDIATRIC POPULATION:
- Older than 12 years of age;
- Patients with a current or previous cancer diagnosis;
- Adequate language proficiency;
- Legal guardians of paediatric cancer patients able to provide informed consent. CAREGIVERS:
- Caregivers and/or family members of cancer patients who lived or assist the loved ones with a current or previous cancer diagnosis in the cancer journey;
- Adequate language proficiency;
- Able to provide informed consent;
- Caregivers and/or family members of paediatric cancer patients under 12 years of age.
- Healthcare professionals with limited oncology patient contact;
- Insufficient knowledge of the local language;
- Severe cognitive impairment, and/or mental disorders that prohibited their participation in the study or inadequate verbal skills that may render them incapable of informed consent (as evaluated by the clinician);
- Inability to understand the study materials (as evaluated by the clinician);
- Physical or psychological impairment that prohibits their participation in focus groups (as evaluated by the clinician).
The study team makes the final eligibility decision.
Where it's taking place
- Caen, France
- Homburg, Germany
- Milan, Italy, Italy
- Vilnius, Lithuania
- Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Caen, France; Homburg, Germany; Milan, Italy, Italy; Vilnius, Lithuania; Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.